Trading Signals: BEAM Stock Price Prediction and Forecast (Thu. Feb. 6, 2020 - Fri. Dec. 22, 2023)(Beam Therapeutics Inc. )
| BEAM latest price $25.7300 (2.27%) ($24.8800 - $26.7500) on Thu. Sep. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5% (three month average) | RSI | 52 | Latest Price | $25.7300(2.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BEAM declines -0.4% a day on average for past five trading days. | Weekly Trend | BEAM declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BEAM advance at 0% a week (0% probability) ARKG(60%) ARKK(59%) XBI(58%) IBB(54%) IWO(54%) | Factors Impacting BEAM price | BEAM will decline at least -2.5% in a week (0% probabilities). VIXM(-27%) UUP(-14%) VXX(-9%) EDOC(-5%) DRIV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.5% (StdDev 5%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $23.82(8.02%) | 10 Day Moving Average | $24.59(4.64%) | 20 Day Moving Average | $24.64(4.42%) | To recent high | -15.8% | To recent low | 35.3% | Market Cap | $1.535b | | | | Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. |